{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:55:43Z","timestamp":1790034943668,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024181","name":"Grail","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.modpat.2025.100890","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:01:22Z","timestamp":1757768482000},"page":"100890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)\u2013Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities"],"prefix":"10.1016","volume":"38","author":[{"given":"Edaise M.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Dessources","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Gordhandas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-1270","authenticated-orcid":false,"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajmohan","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2025.100890_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.modpat.2025.100890_bib2","first-page":"293","article-title":"Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer","volume":"21","author":"Menderes","year":"2016","journal-title":"Discov Med"},{"key":"10.1016\/j.modpat.2025.100890_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ygyno.2009.10.053","article-title":"The impact of multi-modal therapy on survival for uterine carcinosarcomas","volume":"116","author":"Gonzalez Bosquet","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2025.100890_bib5","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/ncomms6006","article-title":"Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes","volume":"5","author":"Jones","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2025.100890_bib6","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2025.100890_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2025.100890_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2025.100890_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2025.100890_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/IGC.0b013e3182434a81","article-title":"Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?","volume":"22","author":"Roelofsen","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.modpat.2025.100890_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2020.04.707","article-title":"Fallopian tube abnormalities in uterine serous carcinoma","volume":"158","author":"Steenbeek","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4132\/jptm.2016.06.17","article-title":"Comparison of the classical method and SEE-FIM protocol in detecting microscopic lesions in fallopian tubes with gynecological lesions","volume":"52","author":"Koc","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.modpat.2025.100890_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3802\/jgo.2013.24.2.114","article-title":"Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: how effective are the macroscopic tubal sampling techniques?","volume":"24","author":"Kulac","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jog.13845","article-title":"Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?","volume":"45","author":"Laokulrath","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.modpat.2025.100890_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib23","series-title":"2020 WHO Classification of Tumours. Female Genital Tumours","author":"Herrington","year":"2020"},{"key":"10.1016\/j.modpat.2025.100890_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/his.12651","article-title":"Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum","volume":"67","author":"Singh","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2025.100890_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jclinpath-2020-207062","article-title":"Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast","volume":"75","author":"da Silva","year":"2022","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.modpat.2025.100890_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41379-020-00721-6","article-title":"Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes","volume":"34","author":"Moukarzel","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/1878-0261.12813","article-title":"The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas","volume":"15","author":"Moukarzel","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2025.100890_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.modpat.2025.100890_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41467-019-13806-x","article-title":"Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2025.100890_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nbt.3391","article-title":"Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity","volume":"34","author":"Chang","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.modpat.2025.100890_bib34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41379-020-0514-3","article-title":"Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary","volume":"33","author":"Da Cruz Paula","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2025.100890_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2017.04.015","article-title":"Frequency of \u201cincidental\u201d serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: a six-year study","volume":"146","author":"Meserve","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100890_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","article-title":"Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series","volume":"39","author":"Morrison","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib38","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.modpat.2025.100890_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0000000000000639","article-title":"Outcomes of incidental fallopian tube high-grade serous carcinoma and serous tubal intraepithelial carcinoma in women at low risk of hereditary breast and ovarian cancer","volume":"26","author":"Chay","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.modpat.2025.100890_bib40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.pas.0000209839.00467.05","article-title":"Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases","volume":"30","author":"Culton","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00428-017-2186-z","article-title":"Clinicopathological characteristics of fallopian tube metastases from primary endometrial, cervical, and nongynecological malignancies: a single institutional experience","volume":"471","author":"Na","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2025.100890_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/path.2848","article-title":"Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas","volume":"223","author":"McConechy","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anndiagpath.2012.10.001","article-title":"Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors","volume":"17","author":"Alvarado-Cabrero","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2025.100890_bib44","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.humpath.2006.11.010","article-title":"Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of fallopian tube neoplasms","volume":"38","author":"Longacre","year":"2007","journal-title":"Hum Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:47:04Z","timestamp":1773150424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0893395225001887"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100890","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)\u2013Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100890"}}